Pegylated Interferon, Ribavirin, and Sofosbuvir Combination versus Pegylated Interferon, Ribavirin in the Management of Chronic Hepatitis C Egyptian Patients
Objective: The aim of this study is to comprehensively evaluate the safety and efficacy of the 20-kDa linear (Pegylated Interferon) PEGIFN alpha-2a and Ribavirin combination versus Sofosbuvir, 20-kDa linear PEGIFN alpha-2a and Ribavirin combination in treatment of chronic hepatitis C (CHC) Egyptian...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Helwan University, Faculty of Pharmacy
2017-01-01
|
| Sarja: | Journal of Advanced Pharmacy Research |
| Aiheet: | |
| Linkit: | https://aprh.journals.ekb.eg/article_16157_80e6626d6bb0ca80894463edc1040f73.pdf |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
